Natco Pharma launches affordable semaglutide injection in India after patent expiry, increasing access to diabetes and weight...
pharma manufacturing
Indian pharma firms seek input price controls as global conflicts disrupt supply chains, causing a cost surge....
India's API exports hit a record in FY25, surpassing imports. This surge, fueled by the PLI scheme,...
Genexis revolutionizes pharma manufacturing, cutting cell culture protein costs tenfold with engineered microbes. Learn how they're transforming...
Indian pharma exporters struggle with rising freight costs and supply chain disruptions due to West Asia tensions....
Cipla USA recalls Nilotinib anti-cancer capsules (150mg and 200mg) due to a manufacturing defect, as confirmed by...
Novo Nordisk's semaglutide is rapidly gaining ground in India's anti-obesity market, challenging Eli Lilly's tirzepatide. Discover how...
India is set to dominate the global homoeopathy market, driven by clinical expertise, strong practitioner networks, and...
Cipla USA recalls Nilotinib Capsules, a cancer drug, due to a manufacturing issue. The Class III recall...
The West Asia conflict fuels economic shifts: soaring private jet demand, potential shipping disruptions, and rising drug...